(CNN) Vaccine advisers to the US Food and Drug Administration decided Tuesday that authorizing Novavax's Covid-19 vaccine -- which uses different technology from the three vaccines currently in use in the US -- for emergency use in adults would be beneficial. If the full FDA gives the vaccine the green light, it will become the fourth Covid-19 vaccine authorized in the United States. Novavax seeks US authorizationIn November, Indonesia became the first country to grant emergency use authorization of Novavax's vaccine. In late January, Novavax announced that it had submitted a request for the FDA to authorize its coronavirus vaccine for emergency use. "We have heard in today's VRBPAC meeting the significant support for our vaccine from physicians, healthcare organizations, and consumers who are eagerly anticipating a protein-based vaccine option," he said.

Source: CNN June 08, 2022 14:09 UTC